My energy and mental clarity are better than they were 10 years ago!" Patricia L
Neuropathy scores improved in seven patients, mostly in patients with immune-mediated neuropathy, but remained unchanged or worsened in the remaining five patients (two patients dropped out due to adverse events that were considered unrelated to B12)
Combining BPC-157 and TB-500 allows researchers to explore coordinated biological responses across multiple tissue repair and regeneration signalling pathways
The FDAs Stance and Why It Misses the Mark In 2023, the FDA classified BPC-157 as a Category 2 bulk drug substance , meaning it raises significant safety concerns. The agency specifically cited risks of immunogenicity , peptide-related impurities , and lack of sufficient safety data for human use
With B12 deficiency becoming common so is supplementing through B12 injections
Some may have mild side effects like pain at the injection site, headache, or dizziness